High expression of CD73 as a poor prognostic biomarker in human colorectal cancer (Q44385757)

2 December 2017

title

High expression of CD73 as a poor prognostic biomarker in human colorectal cancer (English)

1 reference

2 December 2017

0 references

1 reference

Xian-Rui Wu

1

1 reference

2 December 2017

Xiao-Sheng He

2

1 reference

2 December 2017

Yu-Feng Chen

3

1 reference

2 December 2017

Rui-Xue Yuan

4

1 reference

2 December 2017

Yang Zeng

5

1 reference

2 December 2017

Lei Lian

6

1 reference

2 December 2017

Yi-Feng Zou

7

1 reference

2 December 2017

Nan Lan

8

1 reference

2 December 2017

Xiao-Jian Wu

9

1 reference

2 December 2017

Ping Lan

10

1 reference

2 December 2017

publication date

27 January 2012

1 reference

Journal of Surgical Oncology

2 December 2017

published in

1 reference

2 December 2017

volume

106

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

130-137

1 reference

2 December 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Survival from cancer of the rectum in England and Wales up to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Revised staging: is it really better, or do we not know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

CD73: A Novel Target for Cancer Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Extracellular adenosine triphosphate and adenosine in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Ecto-enzyme and signaling functions of lymphocyte CD73

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Physiological roles for ecto-5'-nucleotidase (CD73).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Role of estrogen receptor in the regulation of ecto-5'-nucleotidase and adenosine in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Monte Carlo principles and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Overexpression of nuclear protein kinase CK2 α catalytic subunit (CK2α) as a poor prognosticator in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

Altered purinergic signaling in CD73-deficient mice inhibits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23056

21 January 2018

Identifiers

DOI

10.1002/JSO.23056

1 reference

2 December 2017

1 reference